On September 1, 2021 IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company pioneering a novel class of immunotherapies against difficult-to-treat cancers, reported that members of IMV’s executive management team will be presenting at three investor conferences in September (Press release, IMV, SEP 1, 2021, View Source [SID1234587091]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2021 Virtual Wells Fargo Healthcare Conference

Fireside chat, Thursday, September 9, 2021

9:20 a.m. ET

HC Wainwright 23rd Annual Global Investment Conference

On-demand starting September 13, 2021

7:00 a.m. ET

Cantor Global Healthcare 2021 Conference

Fireside chat, Wednesday, September 29, 2021

11:20 a.m. ET

Webcasts of IMV’s presentations will be accessible in the ‘Events, Webcasts & Presentations’ section of IMV’s website. These webcasts will then be archived following the live presentation and a copy of the presentation will be available at www.imv-inc.com.